These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18201449)

  • 1. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
    Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
    Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM; Kavuru MS; Schilz RJ; Richter JE
    Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
    Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
    Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
    J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.
    Reichel O; Dressel H; Wiederänders K; Issing WJ
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):414-20. PubMed ID: 18722223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
    Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
    Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis.
    DelGaudio JM
    Laryngoscope; 2005 Jun; 115(6):946-57. PubMed ID: 15933499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
    Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
    Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.
    Faruqi S; Molyneux ID; Fathi H; Wright C; Thompson R; Morice AH
    Respirology; 2011 Oct; 16(7):1150-6. PubMed ID: 21707852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relation of GERD, bronchial asthma and the upper respiratory tract].
    Matyásová Z; Novotná B; Matulová M; Dolina J; Kroupa R; Láníková Z; Znojil V; Hep A; Dite P
    Vnitr Lek; 2005 Dec; 51(12):1341-50. PubMed ID: 16430100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
    J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharyngeal pH probe findings in patients with postnasal drainage.
    Loehrl TA; Smith TL; Merati A; Torrico-Brusky L; Hoffman RG; Toohill RJ
    Am J Rhinol; 2005; 19(4):340-3. PubMed ID: 16171165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
    Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
    Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.
    Lam PK; Ng ML; Cheung TK; Wong BY; Tan VP; Fong DY; Wei WI; Wong BC
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):770-6. PubMed ID: 20303417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.